Insider sale
ABIVAX S.A.
$246.60M
2.20M shares
What this filing means
SOFINNOVA CROSSOVER I plans to sell 2.20M shares of ABIVAX S.A. valued at approximately $246.60M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/8/2026ACC: 0001104659-26-001973
2.20M
Shares to sell
$246.60M
Approx. market value
1M
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Private Placement
Cash
7/11/2019
1MTotal acquired1M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/11/2019 | Private Placement Cash | 1M | — |
| Total | 1M | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
609.12K
Market value
$57.26M
10/29/2025
—Completed
Units to sell
590.88K
Market value
$55.64M
10/28/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1M
Market value
$133.70M
1/8/2026
Total
Units
2.20M
Value
$246.60M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/29/2025 | 609.12K | $57.26M | — | Completed |
10/28/2025 | 590.88K | $55.64M | — | Completed |
| Planned — Approximate Date | ||||
1/8/2026 | 1M | $133.70M | NASDAQ | Planned |
| Total | 2.20M | $246.60M | ||